Annual EBITDA
-$8.13 M
+$7.06 M+46.49%
31 December 2023
Summary:
ABVC BioPharma annual earnings before interest, taxes, depreciation & amortization is currently -$8.13 million, with the most recent change of +$7.06 million (+46.49%) on 31 December 2023. During the last 3 years, it has risen by +$2.84 million (+25.88%). ABVC annual EBITDA is now -8132300.00% below its all-time high of -$100.00, reached on 30 September 2014.ABVC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$92.60 K
+$1.20 M+108.34%
30 September 2024
Summary:
ABVC BioPharma quarterly earnings before interest, taxes, depreciation & amortization is currently $92.60 thousand, with the most recent change of +$1.20 million (+108.34%) on 30 September 2024. Over the past year, it has increased by +$2.14 million (+104.53%). ABVC quarterly EBITDA is now -96.24% below its all-time high of $2.46 million, reached on 31 December 2006.ABVC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$6.36 M
+$2.24 M+26.02%
30 September 2024
Summary:
ABVC BioPharma TTM earnings before interest, taxes, depreciation & amortization is currently -$6.36 million, with the most recent change of +$2.24 million (+26.02%) on 30 September 2024. Over the past year, it has increased by +$1.78 million (+21.84%). ABVC TTM EBITDA is now -693.26% below its all-time high of $1.07 million, reached on 31 December 2006.ABVC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABVC EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +104.5% | +21.8% |
| 3 y3 years | +25.9% | +101.6% | +42.1% |
| 5 y5 years | -134.2% | +109.0% | -83.0% |
ABVC EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +46.5% | at high | +101.5% | at high | +64.1% |
| 5 y | 5 years | -134.2% | +46.5% | at high | +101.5% | -83.0% | +64.1% |
| alltime | all time | <-9999.0% | +46.5% | -96.2% | +101.4% | -693.3% | +64.1% |
ABVC BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $92.60 K(-108.3%) | -$6.36 M(-26.0%) |
| June 2024 | - | -$1.11 M(-66.3%) | -$8.59 M(-10.4%) |
| Mar 2024 | - | -$3.29 M(+61.2%) | -$9.59 M(+18.0%) |
| Dec 2023 | -$8.13 M(-46.5%) | -$2.04 M(-4.6%) | -$8.13 M(-14.3%) |
| Sept 2023 | - | -$2.14 M(+1.5%) | -$9.49 M(-13.6%) |
| June 2023 | - | -$2.11 M(+15.1%) | -$10.98 M(+0.9%) |
| Mar 2023 | - | -$1.83 M(-46.0%) | -$10.88 M(-28.4%) |
| Dec 2022 | -$15.20 M(+38.5%) | -$3.40 M(-6.7%) | -$15.20 M(-14.2%) |
| Sept 2022 | - | -$3.64 M(+81.1%) | -$17.71 M(+10.7%) |
| June 2022 | - | -$2.01 M(-67.3%) | -$15.99 M(-0.1%) |
| Mar 2022 | - | -$6.15 M(+4.1%) | -$16.01 M(+45.9%) |
| Dec 2021 | -$10.97 M(+5.8%) | -$5.91 M(+207.8%) | -$10.97 M(+9.8%) |
| Sept 2021 | - | -$1.92 M(-5.3%) | -$9.99 M(-2.3%) |
| June 2021 | - | -$2.03 M(+82.1%) | -$10.22 M(-0.5%) |
| Mar 2021 | - | -$1.11 M(-77.4%) | -$10.28 M(-0.9%) |
| Dec 2020 | -$10.37 M(+198.6%) | -$4.93 M(+129.3%) | -$10.37 M(+60.5%) |
| Sept 2020 | - | -$2.15 M(+3.3%) | -$6.46 M(+18.2%) |
| June 2020 | - | -$2.08 M(+72.5%) | -$5.47 M(+40.5%) |
| Mar 2020 | - | -$1.21 M(+17.8%) | -$3.89 M(+12.1%) |
| Dec 2019 | -$3.47 M(-11.9%) | -$1.02 M(-11.3%) | -$3.47 M(-20.4%) |
| Sept 2019 | - | -$1.15 M(+127.8%) | -$4.36 M(+13.9%) |
| June 2019 | - | -$506.90 K(-35.6%) | -$3.83 M(-4.4%) |
| Mar 2019 | - | -$787.00 K(-58.8%) | -$4.01 M(+2.5%) |
| Dec 2018 | -$3.94 M(-4.7%) | -$1.91 M(+206.7%) | -$3.91 M(+66.3%) |
| Sept 2018 | - | -$623.50 K(-9.0%) | -$2.35 M(-53.8%) |
| June 2018 | - | -$684.90 K(-0.7%) | -$5.09 M(+10.8%) |
| Mar 2018 | - | -$689.60 K(+95.5%) | -$4.59 M(+10.9%) |
| Dec 2017 | -$4.14 M(+3.6%) | -$352.70 K(-89.5%) | -$4.14 M(+3.6%) |
| Sept 2017 | - | -$3.36 M(+1673.8%) | -$4.00 M(+211.1%) |
| Sept 2017 | -$4.00 M(-63.7%) | - | - |
| June 2017 | - | -$189.40 K(-20.0%) | -$1.28 M(-7.2%) |
| Mar 2017 | - | -$236.80 K(+12.5%) | -$1.38 M(-82.2%) |
| Dec 2016 | - | -$210.40 K(-67.5%) | -$7.76 M(-29.8%) |
| Sept 2016 | -$11.00 M(>+9900.0%) | -$647.80 K(+124.5%) | -$11.05 M(+5.9%) |
| June 2016 | - | -$288.60 K(-95.6%) | -$10.43 M(+2.8%) |
| Mar 2016 | - | -$6.61 M(+88.7%) | -$10.14 M(+187.1%) |
| Dec 2015 | - | -$3.50 M(>+9900.0%) | -$3.53 M(>+9900.0%) |
| Sept 2015 | -$32.30 K(>+9900.0%) | -$30.90 K(+1960.0%) | -$32.30 K(+2207.1%) |
| June 2015 | - | -$1500.00(-236.4%) | -$1400.00(-1500.0%) |
| Mar 2015 | - | $1100.00(-210.0%) | $100.00(-110.0%) |
| Dec 2014 | - | -$1000.00(<-9900.0%) | -$1000.00(<-9900.0%) |
| Sept 2014 | -$100.00 | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2014 | - | $0.00(0.0%) | -$11.40 K(-52.3%) |
| Dec 2013 | - | $0.00(0.0%) | -$23.90 K(-84.4%) |
| Sept 2013 | -$153.40 K(-82.6%) | $0.00(-100.0%) | -$153.40 K(-39.3%) |
| June 2013 | - | -$11.40 K(-8.8%) | -$252.80 K(-47.2%) |
| Mar 2013 | - | -$12.50 K(-90.3%) | -$478.90 K(-39.3%) |
| Dec 2012 | - | -$129.50 K(+30.3%) | -$788.90 K(-10.5%) |
| Sept 2012 | -$881.20 K(-10.0%) | -$99.40 K(-58.1%) | -$881.20 K(+178.2%) |
| June 2012 | - | -$237.50 K(-26.4%) | -$316.70 K(-62.5%) |
| Mar 2012 | - | -$322.50 K(+45.4%) | -$844.20 K(+0.1%) |
| Dec 2011 | - | -$221.80 K(-147.7%) | -$843.10 K(-13.9%) |
| Sept 2011 | -$979.60 K(-46.9%) | $465.10 K(-160.8%) | -$979.50 K(-44.8%) |
| June 2011 | - | -$765.00 K(+138.0%) | -$1.78 M(+32.7%) |
| Mar 2011 | - | -$321.40 K(-10.3%) | -$1.34 M(-6.5%) |
| Dec 2010 | - | -$358.20 K(+8.2%) | -$1.43 M(-22.4%) |
| Sept 2010 | -$1.84 M(-62.1%) | -$331.00 K(+1.1%) | -$1.84 M(-18.4%) |
| June 2010 | - | -$327.50 K(-20.8%) | -$2.26 M(-13.4%) |
| Mar 2010 | - | -$413.70 K(-46.4%) | -$2.61 M(-13.2%) |
| Dec 2009 | - | -$771.90 K(+3.3%) | -$3.01 M(-38.0%) |
| Sept 2009 | -$4.87 M(-8.5%) | -$747.50 K(+10.5%) | -$4.85 M(-5.8%) |
| June 2009 | - | -$676.30 K(-16.7%) | -$5.15 M(-10.8%) |
| Mar 2009 | - | -$812.00 K(-69.0%) | -$5.78 M(-11.1%) |
| Dec 2008 | - | -$2.62 M(+150.3%) | -$6.50 M(+22.2%) |
| Sept 2008 | -$5.32 M(+20.8%) | -$1.05 M(-19.6%) | -$5.32 M(+24.5%) |
| June 2008 | - | -$1.30 M(-15.1%) | -$4.27 M(+19.7%) |
| Mar 2008 | - | -$1.53 M(+6.8%) | -$3.57 M(+74.3%) |
| Dec 2007 | - | -$1.44 M(+139.5%) | -$2.05 M(-530.8%) |
| Sept 2007 | -$4.40 M(>+9900.0%) | - | - |
| June 2007 | - | -$599.80 K(+4857.0%) | $475.40 K(-55.5%) |
| Mar 2007 | - | -$12.10 K(-100.5%) | $1.07 M(-0.4%) |
| Dec 2006 | -$26.80 K(+52.3%) | $2.46 M(-279.2%) | $1.07 M(-177.2%) |
| Sept 2006 | - | -$1.37 M(>+9900.0%) | -$1.39 M(+6207.3%) |
| June 2006 | - | -$7600.00(-8.4%) | -$22.00 K(+18.9%) |
| Mar 2006 | - | -$8300.00(-1760.0%) | -$18.50 K(+5.7%) |
| Dec 2005 | -$17.60 K(+20.5%) | $500.00(-107.6%) | -$17.50 K(-57.5%) |
| Sept 2005 | - | -$6600.00(+61.0%) | -$41.20 K(+198.6%) |
| June 2005 | - | -$4100.00(-43.8%) | -$13.80 K(-18.8%) |
| Mar 2005 | - | -$7300.00(-68.5%) | -$17.00 K(+16.4%) |
| Dec 2004 | -$14.60 K(-38.7%) | -$23.20 K(-211.5%) | -$14.60 K(-269.8%) |
| Sept 2004 | - | $20.80 K(-384.9%) | $8600.00(-170.5%) |
| June 2004 | - | -$7300.00(+49.0%) | -$12.20 K(+149.0%) |
| Mar 2004 | - | -$4900.00 | -$4900.00 |
| Dec 2003 | -$23.80 K | - | - |
FAQ
- What is ABVC BioPharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for ABVC BioPharma?
- What is ABVC BioPharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for ABVC BioPharma?
- What is ABVC BioPharma quarterly EBITDA year-on-year change?
- What is ABVC BioPharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for ABVC BioPharma?
- What is ABVC BioPharma TTM EBITDA year-on-year change?
What is ABVC BioPharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ABVC is -$8.13 M
What is the all time high annual EBITDA for ABVC BioPharma?
ABVC BioPharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$100.00
What is ABVC BioPharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ABVC is $92.60 K
What is the all time high quarterly EBITDA for ABVC BioPharma?
ABVC BioPharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.46 M
What is ABVC BioPharma quarterly EBITDA year-on-year change?
Over the past year, ABVC quarterly earnings before interest, taxes, depreciation & amortization has changed by +$2.14 M (+104.53%)
What is ABVC BioPharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ABVC is -$6.36 M
What is the all time high TTM EBITDA for ABVC BioPharma?
ABVC BioPharma all-time high TTM earnings before interest, taxes, depreciation & amortization is $1.07 M
What is ABVC BioPharma TTM EBITDA year-on-year change?
Over the past year, ABVC TTM earnings before interest, taxes, depreciation & amortization has changed by +$1.78 M (+21.84%)